A.J. Cross

11.7k total citations
197 papers, 8.6k citations indexed

About

A.J. Cross is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, A.J. Cross has authored 197 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Cellular and Molecular Neuroscience, 78 papers in Molecular Biology and 26 papers in Physiology. Recurrent topics in A.J. Cross's work include Neuroscience and Neuropharmacology Research (86 papers), Neurotransmitter Receptor Influence on Behavior (37 papers) and Receptor Mechanisms and Signaling (35 papers). A.J. Cross is often cited by papers focused on Neuroscience and Neuropharmacology Research (86 papers), Neurotransmitter Receptor Influence on Behavior (37 papers) and Receptor Mechanisms and Signaling (35 papers). A.J. Cross collaborates with scholars based in United Kingdom, United States and Sweden. A.J. Cross's co-authors include Timothy J. Crow, F. Owen, John L. Waddington, P. Slater, Julie A. Johnson, Elaine K. Perry, Mark Poulter, A. Longden, Guy M. Goodwin and B.E. Tomlinson and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

A.J. Cross

197 papers receiving 8.1k citations

Peers

Countries citing papers authored by A.J. Cross

Since Specialization

Citations

This map shows the geographic impact of A.J. Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.J. Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.J. Cross more than expected).

Fields of papers citing papers by A.J. Cross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.J. Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.J. Cross. The network helps show where A.J. Cross may publish in the future.

Co-authorship network of co-authors of A.J. Cross

This figure shows the co-authorship network connecting the top 25 collaborators of A.J. Cross. A scholar is included among the top collaborators of A.J. Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.J. Cross. A.J. Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Meeting report from the joint IARC–NCI international cancer seminar series: a focus on colorectal cancer 2019 ·Annals of Oncology ·Marc J. Gunter, Samar Alhomoud, Melina Arnold, Hermann Brenner, John Burn, Graham Casey, (unknown), A.J. Cross, Edward L. Giovannucci, Robert N. Hoover, Richard S. Houlston, Mark A. Jenkins, Pierre Laurent‐Puig, Ulrike Peters, David F. Ransohoff, Elio Ríboli, Rashmi Sinha, (unknown), Paul Brennan, (unknown)	51
2	Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis 2018 ·Nature Neuroscience ·Andrew E. Jaffe, Richard E. Straub, Joo Heon Shin, Ran Tao, Yuan Gao, Leonardo Collado‐Torres, Tony Kam-Thong, Hualin Simon Xi, Jie Quan, Qiang Chen, Carlo Colantuoni, William S. Ulrich, Brady J. Maher, Amy Deep‐Soboslay, A.J. Cross, Nicholas J. Brandon, Jeffrey T. Leek, Thomas M. Hyde, Joel E. Kleinman, Daniel R. Weinberger	211
3	Novel inhibitors of As(III) S-adenosylmethionine methyltransferase (AS3MT) identified by virtual screening 2018 ·Bioorganic & Medicinal Chemistry Letters ·Roland W. Bürli, Huijun Wei, (unknown), Abigail Mariga, (unknown), Kara Herlihy, A.J. Cross, Steven S. Wesolowski, Hongming Chen, Ronald D.G. McKay, Daniel R. Weinberger, Nicholas J. Brandon, James C. Barrow	7
4	Attenuation of nicotine-taking and nicotine-seeking behavior by the mGlu2 receptor positive allosteric modulators AZD8418 and AZD8529 in rats 2016 ·Psychopharmacology ·(unknown), Manoranjan S. D’Souza, (unknown), James Doherty, A.J. Cross, Athina Markou	19
5	A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression 2016 ·Psychopharmacology ·Erica M. Richards, Daniel C. Mathews, David A. Luckenbaugh, Dawn F. Ionescu, Rodrigo Machado‐Vieira, Mark J. Niciu, Wallace C. Duncan, Neal M. Nolan, Jose Franco‐Chaves, Thomas J. Hudzik, Carla Maciag, Shuang Li, A.J. Cross, Mark A. Smith, Carlos A. Zarate	59
6	The mGluR2 Positive Allosteric Modulator, AZD8529, and Cue-Induced Relapse to Alcohol Seeking in Rats 2016 ·Neuropsychopharmacology ·Eric Augier, Russell S. Dulman, (unknown), Gaëlle Augier, A.J. Cross, Markus Heilig	30
7	The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys 2015 ·Biological Psychiatry ·Zuzana Justinová, Leigh V. Panlilio, Maria E. Secci, Godfrey H. Redhi, Charles W. Schindler, A.J. Cross, Ladislav Mrzljak, (unknown), Yavin Shaham, Steven R. Goldberg	47
8	Alzheimer's disease research and development: a call for a new research roadmap 2014 ·Annals of the New York Academy of Sciences ·Howard Feldman, Magali Haas, Sam Gandy, Darryle D. Schoepp, A.J. Cross, Richard Mayeux, Reisa A. Sperling, Howard Fillit, (unknown), Sonya Dougal, Jeffrey S. Nye	30
9	Hematologic safety of radium-223 dichloride (Ra-223) in the phase 3 ALSYMPCA trial in castration-resistant prostate cancer (CRPC) patients with bone metastases : baseline prognostic factor subgroup analysis 2013 ·European Journal of Cancer ·Joe M. O’Sullivan, Dag Clement Johannessen, Anders Widmark, Isabel Syndikus, (unknown), Marcos F. Dall’Oglio, I.K. Haugen, A.J. Cross, J. Garcia‐Vargas, N. Vogelzang	3
10	Intra-plaque production of M1-type cytokines and matrix metalloproteinases differentiate stable from unstable carotid atherosclerosis 2011 ·British journal of surgery ·Joseph Shalhoub, A.J. Cross, David Allin, I J Franklin, Claudia Monaco, Alun H. Davies	2
11	Neuroprotective agents and cerebral ischaemia 1997 ·Academic Press eBooks ·(unknown), A.J. Cross	56
12	Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or “Ecstasy”) 1995 ·Psychopharmacology ·(unknown), A.J. Cross, Guy M. Goodwin	326
13	The neurotoxic effects of methamphetamine on 5-hydroxytryptamine and dopamine in brain: Evidence for the protective effect of chlormethiazole 1992 ·Neuropharmacology ·(unknown), (unknown), John A. Williams, T. Murray, A.J. Cross	68
14	Spermidine enhancement of [3H]MK-801 binding to the NMDA receptor complex in human cortical membranes 1990 ·European Journal of Pharmacology Molecular Pharmacology ·(unknown), David M. Bowen, Paul T. Francis, (unknown), A.J. Cross	20
15	Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia 1989 ·Journal of Neurochemistry ·J.F.W. Deakin, P. Slater, M.D.C. Simpson, Anne Gilchrist, Wendy Skan, M.C. Royston, Gavin P. Reynolds, A.J. Cross	324
16	Sodium dependent d-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases 1987 ·Neuroscience Letters ·A.J. Cross, P. Slater, M.D.C. Simpson, (unknown), J.F.W. Deakin, R. H. Perry, Elaine K. Perry	41
17	Autoradiographic Analysis of [³H]Kainic Acid Binding in Primate Braind 1987 ·Journal of Receptor Research ·A.J. Cross, Wendy Skan, P. Slater, Ian Mitchell, A.R. Crossman	8
18	Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease 1981 ·BMJ ·A.J. Cross, Timothy J. Crow, Elaine K. Perry, Robert H. Perry, G. Blessed, B.E. Tomlinson	211
19	Evidence for increased dopamine receptor sensitivity in post mortem brains from patients with schizophrenia [proceedings]. 1978 ·PubMed ·A.J. Cross, (unknown), A. Longden, F. Owen, Mark Poulter, (unknown)	4
20	Inter-relationships between behavioural and neurochemical indices of supersensitivity in dopaminergic neurones [proceedings]. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·A.J. Cross, A. Longden, F. Owen, Mark Poulter, John L. Waddington	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact